Journal of Thoracic Oncology最新文献

筛选
英文 中文
PP01.57 Understanding the molecular mechanism of Supinoxin on Small cell Lung Cancer Therapy PP01.57 了解 Supinoxin 治疗小细胞肺癌的分子机制
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-07-01 DOI: 10.1016/j.jtho.2024.05.292
Subhadeep Das , Matt Russon , Maria P. Zea Rojas , Bennett D. Elzey , Elizabeth Tran
{"title":"PP01.57 Understanding the molecular mechanism of Supinoxin on Small cell Lung Cancer Therapy","authors":"Subhadeep Das , Matt Russon , Maria P. Zea Rojas , Bennett D. Elzey , Elizabeth Tran","doi":"10.1016/j.jtho.2024.05.292","DOIUrl":"https://doi.org/10.1016/j.jtho.2024.05.292","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":null,"pages":null},"PeriodicalIF":21.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141592681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PPD01.86 Phase 1 Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced NSCLC PPD01.86 Fianlimab(一种人类淋巴细胞活化基因-3 (LAG-3)单克隆抗体)与 Cemiplimab 联合治疗晚期 NSCLC 的 1 期研究
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-07-01 DOI: 10.1016/j.jtho.2024.05.159
Byoung Chul Cho , Grace K. Dy , Tae Min Kim , Debashis Sarker , Omid Hamid , Stephen K. Williamson , Sang-We Kim , Hatim Husain , Fang Fang , Shuquan Chen , Jayakumar Mani , Vladimir Jankovic , Anne Paccaly , Sheila Masinde , Israel Lowy , Laura Brennan , Mark Salvati , Matthew Fury , Karl Lewis
{"title":"PPD01.86 Phase 1 Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced NSCLC","authors":"Byoung Chul Cho , Grace K. Dy , Tae Min Kim , Debashis Sarker , Omid Hamid , Stephen K. Williamson , Sang-We Kim , Hatim Husain , Fang Fang , Shuquan Chen , Jayakumar Mani , Vladimir Jankovic , Anne Paccaly , Sheila Masinde , Israel Lowy , Laura Brennan , Mark Salvati , Matthew Fury , Karl Lewis","doi":"10.1016/j.jtho.2024.05.159","DOIUrl":"https://doi.org/10.1016/j.jtho.2024.05.159","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":null,"pages":null},"PeriodicalIF":21.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141592975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PP01.46 Real-World Rebiopsy and Biomarker Retesting Rates Among Patients With Non-Small Cell Lung Cancer Across Patient Demographics in the United States PP01.46 美国非小细胞肺癌患者不同人口统计学特征的真实世界再活检和生物标志物再检测率
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-07-01 DOI: 10.1016/j.jtho.2024.05.285
Charu Aggarwal , Qingqing Xu , Sophia Ng , Rajesh Kamalakar , Samuel Crawford , Sue Beruti , Aida Myftiu , Mary Beth Beasley
{"title":"PP01.46 Real-World Rebiopsy and Biomarker Retesting Rates Among Patients With Non-Small Cell Lung Cancer Across Patient Demographics in the United States","authors":"Charu Aggarwal , Qingqing Xu , Sophia Ng , Rajesh Kamalakar , Samuel Crawford , Sue Beruti , Aida Myftiu , Mary Beth Beasley","doi":"10.1016/j.jtho.2024.05.285","DOIUrl":"https://doi.org/10.1016/j.jtho.2024.05.285","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":null,"pages":null},"PeriodicalIF":21.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141592988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groups in the Forthcoming (Ninth) Edition of the TNM Classification for Lung Cancer IASLC 肺癌分期项目:关于修订即将出版的(第九版)《肺癌 TNM 分期》中 TNM 分期组别的建议。
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-07-01 DOI: 10.1016/j.jtho.2024.02.011
Ramón Rami-Porta MD , Katherine K. Nishimura PhD, MPH , Dorothy J. Giroux MS , Frank Detterbeck MD , Giuseppe Cardillo FRCS, FETCS , John G. Edwards PhD, FRCS(C/Th) , Kwun M. Fong MD, M.B.B.S., FRACP , Meredith Giuliani M.B.B.S. , James Huang MD , Kemp H. Kernstine Sr. MD, PhD , Edith M. Marom MD , Andrew G. Nicholson DM, FRCPath. , Paul E. Van Schil MD , William D. Travis MD , Ming S. Tsao MD , Shun-Ichi Watanabe MD , Valerie W. Rusch MD , Hisao Asamura MD , Members of the IASLC Staging and Prognostic Factors Committee and of the Advisory Boards, and Participating Institutions
{"title":"The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groups in the Forthcoming (Ninth) Edition of the TNM Classification for Lung Cancer","authors":"Ramón Rami-Porta MD ,&nbsp;Katherine K. Nishimura PhD, MPH ,&nbsp;Dorothy J. Giroux MS ,&nbsp;Frank Detterbeck MD ,&nbsp;Giuseppe Cardillo FRCS, FETCS ,&nbsp;John G. Edwards PhD, FRCS(C/Th) ,&nbsp;Kwun M. Fong MD, M.B.B.S., FRACP ,&nbsp;Meredith Giuliani M.B.B.S. ,&nbsp;James Huang MD ,&nbsp;Kemp H. Kernstine Sr. MD, PhD ,&nbsp;Edith M. Marom MD ,&nbsp;Andrew G. Nicholson DM, FRCPath. ,&nbsp;Paul E. Van Schil MD ,&nbsp;William D. Travis MD ,&nbsp;Ming S. Tsao MD ,&nbsp;Shun-Ichi Watanabe MD ,&nbsp;Valerie W. Rusch MD ,&nbsp;Hisao Asamura MD ,&nbsp;Members of the IASLC Staging and Prognostic Factors Committee and of the Advisory Boards, and Participating Institutions","doi":"10.1016/j.jtho.2024.02.011","DOIUrl":"10.1016/j.jtho.2024.02.011","url":null,"abstract":"<div><h3>Introduction</h3><p>The TNM classification of lung cancer is periodically revised. The International Association for the Study of Lung Cancer collected and analyzed a new database to inform the forthcoming ninth edition of the TNM classification. The results are herewith presented.</p></div><div><h3>Methods</h3><p>After exclusions, 76,518 patients from a total of 124,581 registered patients were available for analyses: 58,193 with clinical stage, 39,192 with pathologic stage, and 62,611 with best stage NSCLC. The proposed new N2 subcategories (N2a, involvement of single ipsilateral mediastinal or subcarinal nodal station, and N2b, involvement of multiple ipsilateral mediastinal nodal stations with or without involvement of the subcarinal nodal station) and the new M1c subcategories (M1c1, multiple extrathoracic metastases in one organ system, and M1c2, multiple extrathoracic metastases in multiple organ systems) were considered in the survival analyses. Several potential stage groupings were evaluated, using multiple analyses, including recursive partitioning, assessment of homogeneity within and discrimination between potential groups, clinical and statistical significance of survival differences, multivariable regression, and broad assessment of generalizability.</p></div><div><h3>Results</h3><p>T1N1, T1N2a, and T3N2a subgroups are assigned to IIA, IIB, and IIIA stage groups, respectively. T2aN2b and T2bN2b subgroups are assigned to IIIB. M1c1 and M1c2 remain in stage group IVB. Analyses reveal consistent ordering, discrimination of prognosis, and broad generalizability of the proposed ninth edition stage classification of lung cancer.</p></div><div><h3>Conclusions</h3><p>The proposed stages for the ninth edition TNM improve the granularity of nomenclature about anatomic extent that has benefits as treatment approaches become increasingly differentiated and complex.</p></div>","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":null,"pages":null},"PeriodicalIF":21.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140049791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TOC 技术选择委员会
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-07-01 DOI: 10.1016/S1556-0864(24)00594-X
{"title":"TOC","authors":"","doi":"10.1016/S1556-0864(24)00594-X","DOIUrl":"https://doi.org/10.1016/S1556-0864(24)00594-X","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":null,"pages":null},"PeriodicalIF":21.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S155608642400594X/pdfft?md5=71f09c0b888f1eff88e7998580c2415c&pid=1-s2.0-S155608642400594X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141539238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PP01.112 Treatment Patterns and Outcomes in Second-Line Advanced NSCLC Treated After Prior Platinum Chemotherapy and Immunotherapy Combination Therapy: A Real-World Study PP01.112 既往接受过铂化疗和免疫疗法联合治疗的二线晚期NSCLC的治疗模式和结果:真实世界研究
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-07-01 DOI: 10.1016/j.jtho.2024.05.338
D. Daniel, Ran Gao, S.K. Mhatre, C. Carroll, R. Patel, Joseph Park, D. Haggstrom
{"title":"PP01.112 Treatment Patterns and Outcomes in Second-Line Advanced NSCLC Treated After Prior Platinum Chemotherapy and Immunotherapy Combination Therapy: A Real-World Study","authors":"D. Daniel, Ran Gao, S.K. Mhatre, C. Carroll, R. Patel, Joseph Park, D. Haggstrom","doi":"10.1016/j.jtho.2024.05.338","DOIUrl":"https://doi.org/10.1016/j.jtho.2024.05.338","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":null,"pages":null},"PeriodicalIF":21.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141693101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PP01.101 Estimated Cost of Adverse Events and Surgery for Resectable Non-Small Cell Lung Cancer Patients Receiving Neoadjuvant Nivolumab Plus Platinum-Doublet Chemotherapy PP01.101 可切除的非小细胞肺癌患者接受新辅助 Nivolumab 加铂双联化疗的不良事件和手术费用估算
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-07-01 DOI: 10.1016/j.jtho.2024.05.329
Sherry Wu , Paul Lozowicki , Stefano Lucherini , Sandra Milev , Saurabh Ray , Lien Vo
{"title":"PP01.101 Estimated Cost of Adverse Events and Surgery for Resectable Non-Small Cell Lung Cancer Patients Receiving Neoadjuvant Nivolumab Plus Platinum-Doublet Chemotherapy","authors":"Sherry Wu ,&nbsp;Paul Lozowicki ,&nbsp;Stefano Lucherini ,&nbsp;Sandra Milev ,&nbsp;Saurabh Ray ,&nbsp;Lien Vo","doi":"10.1016/j.jtho.2024.05.329","DOIUrl":"https://doi.org/10.1016/j.jtho.2024.05.329","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":null,"pages":null},"PeriodicalIF":21.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141594277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PP01.36 Applying a Lung Cancer Screening Model on a Real-World Population PP01.36 在现实世界人群中应用肺癌筛查模型
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-07-01 DOI: 10.1016/j.jtho.2024.05.278
Warren R. Coons, Panayiotis Petousis, Ashley E. Prosper, Simon X. Han, Alex A. Bui
{"title":"PP01.36 Applying a Lung Cancer Screening Model on a Real-World Population","authors":"Warren R. Coons,&nbsp;Panayiotis Petousis,&nbsp;Ashley E. Prosper,&nbsp;Simon X. Han,&nbsp;Alex A. Bui","doi":"10.1016/j.jtho.2024.05.278","DOIUrl":"https://doi.org/10.1016/j.jtho.2024.05.278","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":null,"pages":null},"PeriodicalIF":21.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141592800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PP01.15 Healthcare Costs Amongst Patients with Non-Small Cell lung cancer (NSCLC) Before and After Testing with a Host Immune Classifier (HIC) PP01.15 非小细胞肺癌(NSCLC)患者在使用宿主免疫分类器(HIC)检测前后的医疗费用
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-07-01 DOI: 10.1016/j.jtho.2024.05.261
Wade Iams MD , Kimberly Le PharmD, MS, MBA , Nicole Princic MS
{"title":"PP01.15 Healthcare Costs Amongst Patients with Non-Small Cell lung cancer (NSCLC) Before and After Testing with a Host Immune Classifier (HIC)","authors":"Wade Iams MD ,&nbsp;Kimberly Le PharmD, MS, MBA ,&nbsp;Nicole Princic MS","doi":"10.1016/j.jtho.2024.05.261","DOIUrl":"https://doi.org/10.1016/j.jtho.2024.05.261","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":null,"pages":null},"PeriodicalIF":21.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141593084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PP01.22 Single Institution Experience of MRI-Guided Radiotherapy for Thoracic Tumors and Clinical Characteristics Impacting Treatment Duty Cycle PP01.22 MRI引导下胸部肿瘤放疗的单机构经验以及影响治疗周期的临床特征
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-07-01 DOI: 10.1016/j.jtho.2024.05.268
Joseph A. Miccio MD, Nicholas J. Potter PhD, Anaum Showkat, Min Yao MD, Sean Mahase MD, Michele Ferenci PhD, Kaitlin Sisley RTT, Amy Dailey RTT, Jamie Knipple CMD, Amy Blakely CMD, Leonard Tuanquin MD, Mitch Machtay MD
{"title":"PP01.22 Single Institution Experience of MRI-Guided Radiotherapy for Thoracic Tumors and Clinical Characteristics Impacting Treatment Duty Cycle","authors":"Joseph A. Miccio MD,&nbsp;Nicholas J. Potter PhD,&nbsp;Anaum Showkat,&nbsp;Min Yao MD,&nbsp;Sean Mahase MD,&nbsp;Michele Ferenci PhD,&nbsp;Kaitlin Sisley RTT,&nbsp;Amy Dailey RTT,&nbsp;Jamie Knipple CMD,&nbsp;Amy Blakely CMD,&nbsp;Leonard Tuanquin MD,&nbsp;Mitch Machtay MD","doi":"10.1016/j.jtho.2024.05.268","DOIUrl":"https://doi.org/10.1016/j.jtho.2024.05.268","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":null,"pages":null},"PeriodicalIF":21.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141593989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信